TW
NVS icon

TrinityPoint Wealth’s Novartis NVS Stock Holding History

TrinityPoint Wealth’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,348
Closed -$557K – 303
2022
Q1 		$557K Sell
6,348
-326
-5% -$28.2K 0.1% 169
2021
Q4 		$584K Sell
6,674
-66
-1% -$5.48K 0.1% 164
2021
Q3 		$551K Sell
6,740
-141
-2% -$12.7K 0.11% 161
2021
Q2 		$628K Sell
6,881
-179
-3% -$15.9K 0.13% 141
2021
Q1 		$603K Buy
7,060
+61
+0.9% +$5.47K 0.14% 134
2020
Q4 		$671K Buy
6,999
+5
+0.1% +$437 0.16% 121
2020
Q3 		$608K Sell
6,994
-42
-0.6% -$3.64K 0.17% 125
2020
Q2 		$615K Sell
7,036
-180
-2% -$15.5K 0.19% 113
2020
Q1 		$595K Sell
7,216
-142
-2% -$12.7K 0.24% 105
2019
Q4 		$697K Hold
7,358
– – 0.24% 112
2019
Q3 		$647K Buy
7,358
+311
+4% +$27.9K 0.23% 111
2019
Q2 		$658K Sell
7,047
-1,294
-16% -$110K 0.32% 82
2019
Q1 		$719K Sell
8,341
-98
-1% -$7.87K 0.35% 77
2018
Q4 		$649K Buy
+8,439
New +$657K 0.4% 68

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

TrinityPoint Wealth's NVS Position: Q2 2022 in Review

TrinityPoint Wealth sold out of Novartis (NVS) in Q2 2022, closing a stake of 6,348 shares — an estimated $557K sold.

TrinityPoint Wealth first reported a position in NVS in Q4 2018 and held it in 14 quarters. The position peaked at $719K in Q1 2019. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

  • TrinityPoint Wealth reported no remaining Novartis position as of Q2 2022 after selling out during the quarter.
  • TrinityPoint Wealth sold 6,348 Novartis shares in Q2 2022, an estimated $557K.
  • TrinityPoint Wealth first reported a position in Novartis in Q4 2018 and held it in 14 quarters.
  • TrinityPoint Wealth's Novartis position peaked at $719K in Q1 2019.
  • 1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on TrinityPoint Wealth's 13F filing for Q2 2022, filed 5 Aug 2022.